新規登録 | ログイン | FAQ      [?] 

Current Medicinal Chemistry - Anti-Cancer Agents

最近発刊の雑誌の目次より: Current Medicinal Chemistry - Anti-Cancer Agents © Bentham Science Publishers
  • Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 6. (November 2005), pp. 575-589.
    by Chen, , Law, , Loh,
  • Lanthanides as Anticancer Agents
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 6. (November 2005), pp. 591-602.
    by Kostova,
  • Current Drug Therapy for Prostate Cancer: An Overview
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 6. (November 2005), pp. 603-612.
    by Stewart, , Lwaleed, , Douglas, , Birch,
    posted by 1 person zkyken
  • Sulfo-Quinovosyl-Acyl-Glycerol (SQAG), a Eukaryotic DNA Polymerase Inhibitor and Anti-Cancer Agent
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 6. (November 2005), pp. 613-625.
    by Mizushina, , Kasai, , Iijima, , Sugawara, , Yoshida, , Sakaguchi,
  • Lycopene: A Review of Its Potential as an Anticancer Agent
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 6. (November 2005), pp. 627-635.
    by Bhuvaneswari, , Nagini,
  • Selenium Derivatives as Cancer Preventive Agents
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 6. (November 2005), pp. 637-652.
    by Aboul-Fadl,
  • Recent Advances in Understanding and Exploiting the Activation of Anthracyclines by Formaldehyde
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 5. (September 2005), pp. 431-447.
    by SM Cutts, LP Swift, A Rephaeli, A Nudelman, DR Phillips
  • Blocking the PI3K/PKB Pathway in Tumor Cells
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 5. (September 2005), pp. 449-462.
    by F Stauffer, P Holzer, C Garcia-Echeverria
  • Quadruplex-Forming Oligonucleotides as Tools in Anticancer Therapy and Aptamers Design: Energetic Aspects
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 5. (September 2005), pp. 463-475.
    by L Petraccone, G Barone, C Giancola
  • Sesquiterpenes: Natural Products That Decrease Cancer Growth
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 5. (September 2005), pp. 477-499.
    by A Modzelewska, S Sur, SK Kumar, SR Khan
  • Fundamental, Electron Transfer Mechanism by Pyrylium-Type Ions for the Anticancer Drugs 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA) and Flavone-8-Acetic Acid (FAA)
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 5. (September 2005), pp. 501-506.
    by P Kovacic
  • Steroid Sulfatase Inhibitors: Their Potential in the Therapy of Breast Cancer
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 5. (September 2005), pp. 507-528.
    by P Nussbaumer, A Billich
  • Histone Deacetylase Inhibitors: Latest Developments, Trends and Prospects
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 5. (September 2005), pp. 529-560.
    by O Moradei, CR Maroun, I Paquin, A Vaisburg
  • An Analysis of the Binding Modes of ATP-Competitive CDK2 Inhibitors as Revealed by X-Ray Structures of Protein-Inhibitor Complexes
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 5. (September 2005), pp. 561-573.
    by A Vulpetti, P Pevarello
  • Editorial Hot Topic: The Chemistry and Biology of Small Molecules Acting on Nucleic Acids (Guest Editors: P.B. Arimondo, T. Garestier, J.-L. Mergny Dedicated to the Memory of Professor Claude Helene)
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 4. (July 2005), pp. 315-317.
    by P Arimondo, T Garestier, J Mergny
  • Triplex-Forming Oligonucleotides as Potential Tools for Modulation of Gene Expression
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 4. (July 2005), pp. 319-326.
    by F Rogers, J Lloyd, P Glazer
  • Recognition of Triple Helical Nucleic Acids by Aminoglycosides
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 4. (July 2005), pp. 327-338.
    by H Xi, D Arya
  • Competition Dialysis: An Assay to Measure the Structural Selectivity of Drug-Nucleic Acid Interactions
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 4. (July 2005), pp. 339-352.
    by J Chaires
  • Camptothecin: Roles of the D and E Rings in Binding to the Topoisomerase I-DNA Covalent Binary Complex
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 4. (July 2005), pp. 353-362.
    by S Hecht
  • Etoposide, Topoisomerase II and Cancer
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 4. (July 2005), pp. 363-372.
    by E Baldwin, N Osheroff
  • Programmable DNA Binding Oligomers for Control of Transcription
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 4. (July 2005), pp. 373-387.
    by P Dervan, R Doss, M Marques
  • Dications That Target the DNA Minor Groove: Compound Design and Preparation, DNA Interactions, Cellular Distribution and Biological Activity
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 4. (July 2005), pp. 389-408.
    by W Wilson, B Nguyen, F Tanious, A Mathis, J Hall, C Stephens, D Boykin
  • Target Practice: Aiming at Satellite Repeats with DNA Minor Groove Binders
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 4. (July 2005), pp. 409-420.
    by G Susbielle, R Blattes, V Brevet, C Monod, E Kas
  • Interfacial Inhibitors of Protein-Nucleic Acid Interactions
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 4. (July 2005), pp. 421-429.
    by Y Pommier, C Marchand
  • DNA Helicases as Targets for Anti-Cancer Drugs
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 3. (May 2005), pp. 183-199.
    by Sudha Sharma, Kevin M Doherty, RM Brosh
  • Prospects for Plant-Derived Chemopreventive Agents Exhibiting Multiple Mechanisms of Action
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 3. (May 2005), pp. 201-213.
    by L Howells, M Manson
  • Synthesis and Biological Activity of New Class of Dioxygenated Anticancer Agents
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 3. (May 2005), pp. 215-237.
    by Maria D Pujol, Manel Romero, Isabel Sanchez
  • Anti-Cancer Potential of Sesquiterpene Lactones: Bioactivity and Molecular Mechanisms
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 3. (May 2005), pp. 239-249.
    by Siyuan Zhang, Yen-Kim Won, Choon-Nam Ong, Han-Ming Shen
  • Cisplatin Is a DNA-Damaging Antitumour Compound Triggering Multifactorial Biochemical Responses in Cancer Cells: Importance of Apoptotic Pathways
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 3. (May 2005), pp. 251-265.
    by Yuliya Sedletska, Marie-Josephe Giraud-Panis, Jean-Marc Malinge
  • Multi-Nuclear Platinum Drugs: A New Paradigm in Chemotherapy
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 3. (May 2005), pp. 267-279.
    by Nial J Wheate, J Collins
  • Progress in the Development of Aminopeptidase N (APN/CD13) Inhibitors
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 3. (May 2005), pp. 281-301.
    by Wenfang Xu, Qianbin Li
  • Lanthanide Bearing Microparticulate Systems for Multi-Modality Imaging and Targeted Therapy of Cancer
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 3. (May 2005), pp. 303-313.
    by S Zielhuis, J Nijsen, J Seppenwoolde, B Zonnenberg, C Bakker, W Hennink, PP Rijk, AD Schip
  • Monoclonal Antibody-Based Targeted Therapy in Breast Cancer
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 2. (March 2005), pp. 99-106.
    by Kadri Altundag, Francisco J Esteva, Banu Arun
  • Development of Prodrugs for Enzyme-Mediated, Tumor-Selective Therapy
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 2. (March 2005), pp. 107-113.
    by KJ Yoon, Philip M Potter, Mary K Danks
  • Anti-Angiogenic Therapy as a Cancer Treatment Paradigm
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 2. (March 2005), pp. 115-130.
    by Mohanraj Dhanabal, Mike Jeffers, William J Larochelle
  • Activation of p53 by Specific Agents in Potential Cancer Therapy
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 2. (March 2005), pp. 131-135.
    by John W Ho, Jing Z Song, YK Yuet
  • Metal Complexes with Aromatic N-Containing Ligands as Potential Agents in Cancer Treatment
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 2. (March 2005), pp. 137-147.
    by Guanghua Zhao, Huakuan Lin
  • Medicinal Properties of Neem Leaves: A Review
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 2. (March 2005), pp. 149-156.
    by R Subapriya, S Nagini
  • Specific Targets in Tumor Tissue for the Delivery of Therapeutic Genes
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 2. (March 2005), pp. 157-171.
    by Michael Gunther, Ernst Wagner, Manfred Ogris
  • Cytotoxic and Antitumor Potentialities of Aporphinoid Alkaloids
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 2. (March 2005), pp. 173-182.
    by C Stevigny, C Bailly, J Quetin-Leclercq
  • The Impact of Tumor Physiology on Camptothecin-Based Drug Development
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 1., 1.
    by David J Adams
  • Cisplatin Resistance and Transcription Factors
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 1., 15.
    by Takayuki Torigoe, Hiroto Izumi, Hiroshi Ishiguchi, Yoichiro Yoshida, Mizuho Tanabe, Takeshi Yoshida, Tomonori Igarashi, Ichiro Niina, Tetsuro Wakasugi, Takuya Imaizumi, Yasutomo Momii, Michihiko Kuwano, Kimitoshi Kohno
  • Synthetic and Natural Coumarins as Cytotoxic Agents
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 1., 29.
    by Irena Kostova
  • Chemical Aspects of Coumarin Compounds for the Prevention of Hepatocellular Carcinomas
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 1., 47.
    by Toshihiro Okamoto, Tadashi Kobayashi, Shinichi Yoshida
  • Novel Anticancer Targets and Drug Discovery in Post Genomic Age
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 1., 53.
    by Qianbin Li, Wenfang Xu
  • Targeting Microtubules for Cancer Chemotherapy
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 1., 65.
    by Jun Zhou, Paraskevi Giannakakou
  • Chemoresistance in Non-Small Cell Lung Cancer
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 1., 73.
    by Pascal Seve, Charles Dumontet
  • author Index to Volume 4
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 1., 89.
    by Bentham S Publishers
  • Subject Index to Volume 4
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, No. 1., 91.
    by Bentham S Publishers
  • Can PPARgamma Ligands Be Used in Cancer Therapy?
    Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, No. 6., 465.
    by MA Rumi, S Ishihara, H Kazumori, Y Kadowaki, Y Kinoshita
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/journal/ben-cmcaca

    Result page: 1 2 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.